Longitudinal changes in hemostatic parameters and reduced pulsatility contribute to non-surgical bleeding in patients with centrifugal continuous-flow left ventricular assist devices

Journal of Heart and Lung Transplantation

Volumn 35, Issue 6, 2016, Pages 743-751

  Muthiah, Kavitha ^a,b,c   Connor, David ^a   Ly, Ken ^a   Gardiner, Elizabeth E ^d   Andrews, Robert K ^d   Qiao, Jianlin ^d   Rutgers, Darren ^a   Robson, Desiree ^a   Low, Joyce ^a   Jarvis, Susan ^a   Macdonald, Peter ^a,b,c   Dhital, Kumud ^a,b   Jansz, Paul ^a,b   Joseph, Joanne ^a,b   Hayward, Christopher S ^a,b,c  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

acquired von Willebrand syndrome; bleeding; continuous flow; hemostatic biomarkers; left ventricular assist device

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN VI; HEMOGLOBIN; PADGEM PROTEIN; VON WILLEBRAND FACTOR; HEMOSTATIC AGENT;

ADULT; AGED; AORTA VALVE; AORTIC VALVE OPENING; ARTICLE; BIVENTRICULAR ASSIST DEVICE; BLEEDING; BLOOD CLOTTING; BRAIN EMBOLISM; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL TRIAL; COLLAGEN BINDING ACTIVITY TO ANTIGEN RATIO; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART VENTRICLE THROMBOSIS; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMATOMA; HEMOPTYSIS; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRAAORTIC BALLOON PUMP; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PLATELET AGGREGATION ASSAY; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME ULTRASOUND SCANNER; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY; HEART ASSIST DEVICE; VON WILLEBRAND DISEASE;

HEART-ASSIST DEVICES; HEMORRHAGE; HEMOSTATICS; HUMANS; PROSPECTIVE STUDIES; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84960540625     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2015.12.024     Document Type: Article

References (30)

1. C.S. Hayward, and M. Schwartz The evolution of ventricular assist devices and the HeartWare ventricular assist system Eur Cardiol 8 2012 32 35
2. K.D. Aaronson, M.S. Slaughter, L.W. Miller, and et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation Circulation 125 2012 3191 3200
3. A.F. Popov, M.T. Hosseini, B. Zych, and et al. Clinical experience with HeartWare left ventricular assist device in patients with end-stage heart failure Ann Thorac Surg 93 2012 810 815
4. J.A. Larose, D. Tamez, M. Ashenuga, and C. Reyes Design concepts and principle of operation of the HeartWare ventricular assist system ASAIO J 56 2010 285 289
5. H.M. Tsai, Sussman II, and R.L. Nagel Shear stress enhances the proteolysis of von Willebrand factor in normal plasma Blood 83 1994 2171 2179
6. A.L. Meyer, D. Malehsa, C. Bara, and et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device Circ Heart Fail 3 2010 675 681
7. S. Crow, R. John, A. Boyle, and et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices J Thorac Cardiovasc Surg 137 2009 208 215
8. P. Diehl, M. Aleker, T. Helbing, and et al. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation Interact Cardiovasc Thorac Surg 11 2010 133 137
9. M. Al-Tamimi, C.W. Tan, J. Qiao, and et al. Pathologic shear triggers shedding of vascular receptors: a novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vessels Blood 119 2012 4311 4320
10. M. Al-Tamimi, J.F. Arthur, E. Gardiner, and R.K. Andrews Focusing on plasma glycoprotein VI Thromb Haemost 107 2012 648 655
11. O. Wever-Pinzon, C.H. Selzman, S.G. Drakos, and et al. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II Circ Heart Fail 6 2013 517 526
12. D.R. Stern, J. Kazam, P. Edwards, and et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD J Card Surg 25 2010 352 356
13. H.J. Zhao, Z.T. Zheng, Z.H. Wang, and et al. "Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment Chest 139 2011 260 270
14. N. Uriel, S.W. Pak, U.P. Jorde, and et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation J Am Coll Cardiol 56 2010 1207 1213
15. M.S. Slaughter Hematologic effects of continuous flow left ventricular assist devices J Cardiovasc Transl Res 3 2010 618 624
16. J. Suarez, C.B. Patel, G.M. Felker, R. Becker, A.F. Hernandez, and J.G. Rogers Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices Circ Heart Fail 4 2011 779 784
17. J. Klovaite, F. Gustafsson, S.A. Mortensen, K. Sander, and L.B. Nielsen Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II) J Am Coll Cardiol 53 2009 2162 2167
18. U. Geisen, C. Heilmann, F. Beyersdorf, and et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease Eur J Cardiothorac Surg 33 2008 679 684
19. T.E. Warkentin, J.C. Moore, and D.G. Morgan Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet 340 1992 35 37
20. S. Crow, C. Milano, L. Joyce, and et al. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients ASAIO J 56 2010 441 445
21. Y. Yamashita, K. Naitoh, H. Wada, and et al. Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy Thromb Res 133 2014 440 444
22. J.F. Arthur, S. Dunkley, and R.K. Andrews Platelet glycoprotein VI-related clinical defects Br J Haematol 139 2007 363 372
23. J. Hu, N.K. Mondal, E.N. Sorensen, and et al. Platelet glycoprotein Ibalpha ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices J Heart Lung Transplant 33 2014 71 79
24. S. Kapoor, S. Pal, P. Sahni, and T.K. Chattopadhyay Thromboelastographic evaluation of coagulation in patients with extrahepatic portal vein thrombosis and non-cirrhotic portal fibrosis: a pilot study J Gastroenterol Hepatol 24 2009 992 997
25. D.J. McCrath, E. Cerboni, R.J. Frumento, A.L. Hirsh, and E. Bennett-Guerrero Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction Anesth Analg 100 2005 1576 1583
26. S.F. Mause Platelet microparticles: reinforcing the hegemony of platelets in atherothrombosis Thromb Haemost 109 2013 5 6
27. L. Burnier, P. Fontana, B.R. Kwak, and A. Angelillo-Scherrer Cell-derived microparticles in haemostasis and vascular medicine Thromb Haemost 101 2009 439 451
28. M. Namba, A. Tanaka, K. Shimada, and et al. Circulating platelet-derived microparticles are associated with atherothrombotic events: a marker for vulnerable blood Arterioscler Thromb Vasc Biol 27 2007 255 256
29. R. Suades, T. Padro, G. Vilahur, and L. Badimon Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques Thromb Haemost 108 2012 1208 1219
30. M.S. Slaughter, M.A. Sobieski 2nd, J.D. Graham, P.S. Pappas, A.J. Tatooles, and S.C. Koenig Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device Int J Artif Organs 34 2011 461 468